First RSV vaccine could be approved this summer

(NEW YORK) -- After decades of research, a first-of-its kind vaccine designed to protect newborns against RSV, or respiratory syncytial virus, could be approved by August.Pfizer, the maker of the vaccine, announced Tuesday that the U.S. Food and Drug Administration has accepted its application... Read More.